SlideShare ist ein Scribd-Unternehmen logo
1 von 26
David Cram, Pharm.D. Associate Director, MSL Program Genentech PLEASE NOTE THAT THESE ARE MY VIEWS AND NOT NECESSARILY THOSE OF GENENTECH
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
1 Million $ per Day
[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Update
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Update
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Weitere ähnliche Inhalte

Was ist angesagt?

Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Best Practices
 
KOL Relationship Management in Pharma
KOL Relationship Management in PharmaKOL Relationship Management in Pharma
KOL Relationship Management in PharmaAnup Soans
 
Medical & Scientific Affairs (M & SA)
Medical & Scientific Affairs (M & SA)Medical & Scientific Affairs (M & SA)
Medical & Scientific Affairs (M & SA)Dr Karthik Anantharaman
 
Medical Affairs Leadership Summit, Key APAC Insights - August 2016
Medical Affairs Leadership Summit, Key APAC Insights - August 2016Medical Affairs Leadership Summit, Key APAC Insights - August 2016
Medical Affairs Leadership Summit, Key APAC Insights - August 2016Lynn Okamoto
 
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...Best Practices
 
Benchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs FunctionsBenchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs FunctionsIndustry Standard Research
 
Key Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
Key Opinion Leader Compensation and KOL and Medical Science Liaison InteractionsKey Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
Key Opinion Leader Compensation and KOL and Medical Science Liaison InteractionsMedical Science Liaison Society
 
Medical affairs department for small organization
Medical affairs department for small organizationMedical affairs department for small organization
Medical affairs department for small organizationDr. Zubair Ali
 
Coaching Action Plan for MSL - Investigator Initiated Trials
Coaching Action Plan for MSL - Investigator Initiated TrialsCoaching Action Plan for MSL - Investigator Initiated Trials
Coaching Action Plan for MSL - Investigator Initiated TrialsMarieke Jonkman PharmD
 
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report SummaryMedical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report SummaryBest Practices
 
Strategic Medical Affairs in pharma and medical devices
Strategic Medical Affairs in pharma and medical devicesStrategic Medical Affairs in pharma and medical devices
Strategic Medical Affairs in pharma and medical devicesAnjan Banerjee
 
Medical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report SummaryMedical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report SummaryBest Practices, LLC
 
Medical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report SummaryMedical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report SummaryBest Practices, LLC
 
Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...
Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...
Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...Best Practices
 
New Health Report 2011 Il
New Health Report 2011 IlNew Health Report 2011 Il
New Health Report 2011 IlJohnsrud
 
Hospitals Care Systems Of Future
Hospitals Care Systems Of FutureHospitals Care Systems Of Future
Hospitals Care Systems Of FutureJohnsrud
 
How to build a "better top team"
How to build a "better top team"How to build a "better top team"
How to build a "better top team"Johnsrud
 

Was ist angesagt? (20)

Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
 
KOL Relationship Management in Pharma
KOL Relationship Management in PharmaKOL Relationship Management in Pharma
KOL Relationship Management in Pharma
 
Medical & Scientific Affairs (M & SA)
Medical & Scientific Affairs (M & SA)Medical & Scientific Affairs (M & SA)
Medical & Scientific Affairs (M & SA)
 
Medical Affairs Leadership Summit, Key APAC Insights - August 2016
Medical Affairs Leadership Summit, Key APAC Insights - August 2016Medical Affairs Leadership Summit, Key APAC Insights - August 2016
Medical Affairs Leadership Summit, Key APAC Insights - August 2016
 
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...
 
Benchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs FunctionsBenchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs Functions
 
Key Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
Key Opinion Leader Compensation and KOL and Medical Science Liaison InteractionsKey Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
Key Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
 
KOL MANAGEMENT
KOL MANAGEMENTKOL MANAGEMENT
KOL MANAGEMENT
 
Medical affairs department for small organization
Medical affairs department for small organizationMedical affairs department for small organization
Medical affairs department for small organization
 
Trends in Medical Affairs
Trends in Medical AffairsTrends in Medical Affairs
Trends in Medical Affairs
 
Coaching Action Plan for MSL - Investigator Initiated Trials
Coaching Action Plan for MSL - Investigator Initiated TrialsCoaching Action Plan for MSL - Investigator Initiated Trials
Coaching Action Plan for MSL - Investigator Initiated Trials
 
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report SummaryMedical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary
 
Strategic Medical Affairs in pharma and medical devices
Strategic Medical Affairs in pharma and medical devicesStrategic Medical Affairs in pharma and medical devices
Strategic Medical Affairs in pharma and medical devices
 
Medical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report SummaryMedical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report Summary
 
Medical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report SummaryMedical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report Summary
 
Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...
Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...
Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...
 
New Health Report 2011 Il
New Health Report 2011 IlNew Health Report 2011 Il
New Health Report 2011 Il
 
Hospitals Care Systems Of Future
Hospitals Care Systems Of FutureHospitals Care Systems Of Future
Hospitals Care Systems Of Future
 
Two Heads
Two HeadsTwo Heads
Two Heads
 
How to build a "better top team"
How to build a "better top team"How to build a "better top team"
How to build a "better top team"
 

Andere mochten auch

5 powerful ideas on KOL network management
5 powerful ideas on KOL network management5 powerful ideas on KOL network management
5 powerful ideas on KOL network managementexecutiveinsight
 
The Medical Science Liaison (MSL) & Social Networking
The Medical Science Liaison (MSL) & Social NetworkingThe Medical Science Liaison (MSL) & Social Networking
The Medical Science Liaison (MSL) & Social NetworkingStephen Dodge
 
Medical Affairs Asia Forum 2014
Medical Affairs Asia Forum 2014 Medical Affairs Asia Forum 2014
Medical Affairs Asia Forum 2014 Rita Barry
 
Optimizing KOL Relationships Report Summary
Optimizing KOL Relationships Report SummaryOptimizing KOL Relationships Report Summary
Optimizing KOL Relationships Report SummaryBest Practices
 
Key Opinion Leader Management
Key Opinion Leader ManagementKey Opinion Leader Management
Key Opinion Leader ManagementJames Wiliam
 
Medical Affairs Consortium
Medical Affairs ConsortiumMedical Affairs Consortium
Medical Affairs ConsortiumBest Practices
 
10 essential questions for successful kol management
10 essential questions for successful kol management10 essential questions for successful kol management
10 essential questions for successful kol managementexecutiveinsight
 

Andere mochten auch (7)

5 powerful ideas on KOL network management
5 powerful ideas on KOL network management5 powerful ideas on KOL network management
5 powerful ideas on KOL network management
 
The Medical Science Liaison (MSL) & Social Networking
The Medical Science Liaison (MSL) & Social NetworkingThe Medical Science Liaison (MSL) & Social Networking
The Medical Science Liaison (MSL) & Social Networking
 
Medical Affairs Asia Forum 2014
Medical Affairs Asia Forum 2014 Medical Affairs Asia Forum 2014
Medical Affairs Asia Forum 2014
 
Optimizing KOL Relationships Report Summary
Optimizing KOL Relationships Report SummaryOptimizing KOL Relationships Report Summary
Optimizing KOL Relationships Report Summary
 
Key Opinion Leader Management
Key Opinion Leader ManagementKey Opinion Leader Management
Key Opinion Leader Management
 
Medical Affairs Consortium
Medical Affairs ConsortiumMedical Affairs Consortium
Medical Affairs Consortium
 
10 essential questions for successful kol management
10 essential questions for successful kol management10 essential questions for successful kol management
10 essential questions for successful kol management
 

Ähnlich wie Development Msl

Clinical Recruitment Planning Strategies
Clinical Recruitment Planning StrategiesClinical Recruitment Planning Strategies
Clinical Recruitment Planning StrategiesMFinch3777
 
Medical Science Liaison Webinarv 2009
Medical Science Liaison  Webinarv  2009Medical Science Liaison  Webinarv  2009
Medical Science Liaison Webinarv 2009Cameron Tew
 
Best in-class Medical Science Liasons
Best in-class Medical Science LiasonsBest in-class Medical Science Liasons
Best in-class Medical Science LiasonsJean-Michel Peny
 
Tricks of the Trade: Patient Recruitment & Retention for Different Study Types
Tricks of the Trade: Patient Recruitment & Retention for Different Study TypesTricks of the Trade: Patient Recruitment & Retention for Different Study Types
Tricks of the Trade: Patient Recruitment & Retention for Different Study TypesImperial CRS
 
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...Best Practices, LLC
 
Precision Medicine and Evolving Drug Development in China
Precision Medicine and Evolving Drug Development in ChinaPrecision Medicine and Evolving Drug Development in China
Precision Medicine and Evolving Drug Development in ChinaCovance
 
The Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White PaperThe Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White PaperCovance
 
Assignment Steps Resources Tutorial help on Excel® and Word fun.docx
Assignment Steps Resources Tutorial help on Excel® and Word fun.docxAssignment Steps Resources Tutorial help on Excel® and Word fun.docx
Assignment Steps Resources Tutorial help on Excel® and Word fun.docxlynettearnold46882
 
Myelin repair open science summit 07.31.10 v2
Myelin repair   open science summit 07.31.10 v2Myelin repair   open science summit 07.31.10 v2
Myelin repair open science summit 07.31.10 v2Open Science Summit
 
Clinical Pharmacology: Leveraging Science to Provide Access
Clinical Pharmacology: Leveraging Science to Provide AccessClinical Pharmacology: Leveraging Science to Provide Access
Clinical Pharmacology: Leveraging Science to Provide AccessE. Dennis Bashaw
 
Disseminate Clinical Data Early to Support Payer Coverage Decisions
Disseminate Clinical Data Early to Support Payer Coverage DecisionsDisseminate Clinical Data Early to Support Payer Coverage Decisions
Disseminate Clinical Data Early to Support Payer Coverage DecisionsTodd Berner MD
 
Dr. Anoop Medical Advisor CV (2)
Dr. Anoop Medical Advisor CV (2)Dr. Anoop Medical Advisor CV (2)
Dr. Anoop Medical Advisor CV (2)Dr.Anoop Hajare
 
Solving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trialsSolving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trialsRoberto Lara
 
Improving Chronic Care - a NZ experience using a breakthrough series collabor...
Improving Chronic Care - a NZ experience using a breakthrough series collabor...Improving Chronic Care - a NZ experience using a breakthrough series collabor...
Improving Chronic Care - a NZ experience using a breakthrough series collabor...Health Informatics New Zealand
 
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...CTSI at UCSF
 
Do you know how many rewarding job opportunities exist in the Clinical resea...
Do you know how many rewarding  job opportunities exist in the Clinical resea...Do you know how many rewarding  job opportunities exist in the Clinical resea...
Do you know how many rewarding job opportunities exist in the Clinical resea...Access-Pharma Jobs
 
Scenario A specialty memory chip manufacturer is located in South.docx
Scenario A specialty memory chip manufacturer is located in South.docxScenario A specialty memory chip manufacturer is located in South.docx
Scenario A specialty memory chip manufacturer is located in South.docxkenjordan97598
 

Ähnlich wie Development Msl (20)

Clinical Recruitment Planning Strategies
Clinical Recruitment Planning StrategiesClinical Recruitment Planning Strategies
Clinical Recruitment Planning Strategies
 
Medical Science Liaison Webinarv 2009
Medical Science Liaison  Webinarv  2009Medical Science Liaison  Webinarv  2009
Medical Science Liaison Webinarv 2009
 
Best in-class Medical Science Liasons
Best in-class Medical Science LiasonsBest in-class Medical Science Liasons
Best in-class Medical Science Liasons
 
Tricks of the Trade: Patient Recruitment & Retention for Different Study Types
Tricks of the Trade: Patient Recruitment & Retention for Different Study TypesTricks of the Trade: Patient Recruitment & Retention for Different Study Types
Tricks of the Trade: Patient Recruitment & Retention for Different Study Types
 
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
 
Precision Medicine and Evolving Drug Development in China
Precision Medicine and Evolving Drug Development in ChinaPrecision Medicine and Evolving Drug Development in China
Precision Medicine and Evolving Drug Development in China
 
The Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White PaperThe Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White Paper
 
Assignment Steps Resources Tutorial help on Excel® and Word fun.docx
Assignment Steps Resources Tutorial help on Excel® and Word fun.docxAssignment Steps Resources Tutorial help on Excel® and Word fun.docx
Assignment Steps Resources Tutorial help on Excel® and Word fun.docx
 
Regulation reimbursement and evidence on NMT
Regulation reimbursement and evidence on NMTRegulation reimbursement and evidence on NMT
Regulation reimbursement and evidence on NMT
 
Myelin repair open science summit 07.31.10 v2
Myelin repair   open science summit 07.31.10 v2Myelin repair   open science summit 07.31.10 v2
Myelin repair open science summit 07.31.10 v2
 
Clinical Pharmacology: Leveraging Science to Provide Access
Clinical Pharmacology: Leveraging Science to Provide AccessClinical Pharmacology: Leveraging Science to Provide Access
Clinical Pharmacology: Leveraging Science to Provide Access
 
pc15147_brochure
pc15147_brochurepc15147_brochure
pc15147_brochure
 
Disseminate Clinical Data Early to Support Payer Coverage Decisions
Disseminate Clinical Data Early to Support Payer Coverage DecisionsDisseminate Clinical Data Early to Support Payer Coverage Decisions
Disseminate Clinical Data Early to Support Payer Coverage Decisions
 
Dr. Anoop Medical Advisor CV (2)
Dr. Anoop Medical Advisor CV (2)Dr. Anoop Medical Advisor CV (2)
Dr. Anoop Medical Advisor CV (2)
 
Solving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trialsSolving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trials
 
Improving Chronic Care - a NZ experience using a breakthrough series collabor...
Improving Chronic Care - a NZ experience using a breakthrough series collabor...Improving Chronic Care - a NZ experience using a breakthrough series collabor...
Improving Chronic Care - a NZ experience using a breakthrough series collabor...
 
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
 
Do you know how many rewarding job opportunities exist in the Clinical resea...
Do you know how many rewarding  job opportunities exist in the Clinical resea...Do you know how many rewarding  job opportunities exist in the Clinical resea...
Do you know how many rewarding job opportunities exist in the Clinical resea...
 
BBCR Innovation Approach
BBCR Innovation ApproachBBCR Innovation Approach
BBCR Innovation Approach
 
Scenario A specialty memory chip manufacturer is located in South.docx
Scenario A specialty memory chip manufacturer is located in South.docxScenario A specialty memory chip manufacturer is located in South.docx
Scenario A specialty memory chip manufacturer is located in South.docx
 

Development Msl

  • 1. David Cram, Pharm.D. Associate Director, MSL Program Genentech PLEASE NOTE THAT THESE ARE MY VIEWS AND NOT NECESSARILY THOSE OF GENENTECH
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.  
  • 7. 1 Million $ per Day
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.